Is C83.89 a billable ICD-10-CM code?

Yes. C83.89 is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does C83.89 sit in the tabular list?

Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).

C83.89

C83.89 — Other non-follicular lymphoma, extranodal and solid organ sites

Billable / specific codeICD-10-CM

C83.89 is a billable, specific ICD-10-CM code for other non-follicular lymphoma, extranodal and solid organ sites. It is valid for submission on a claim.

Other codes that can never be billed with C83.89

These codes carry an Excludes1 note pointing at C83.89. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading C83.89 alone.

C83.390Primary central nervous system lymphoma

Risk adjustment

C83.89 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 21 Lymphoma and Other Cancers0.671 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

C83.89 is named in 58 Medicare coverage policies — 58 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52370Billing and Coding: Bevacizumab and biosimilars
A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article

Related codes at this level

Codes that share C83.8. If C83.89 is not quite right, the correct code is usually one of these.

Questions about C83.89

Is C83.89 a billable ICD-10-CM code?: Yes. C83.89 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does C83.89 sit in the tabular list?: Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).